Meanwhile, Noon et al. also stated that because there was no evidence to support the conclusion that p53 mutation is associated with poorer survival, it seemed clear that increased p53 expression in RCC occurs independent of mutation [135]. The gene discussed is TP53; the disease is renal cell carcinoma.